Table 8.
Comparison of treatment in successful and complicated pregnancy.
| Treatment | Adverse pregnancy outcome (n = 50) (17.7%) | Successful pregnancies (n = 233) (82.3%) | p-Value |
|---|---|---|---|
| LDA monotherapy (n = 67) | 9/50 (18) | 58/233 (24.9) | NS |
| LMWH monotherapy (n = 5) | 3/50 (6) | 2/233 (0.8) | 0.040* |
| LDA + LMWH (n = 211) | 38/50 (76) | 173/233 (74.2) | NS |
| LDA + LMWH prophylactic dosage (n = 161) | 28/50 (56) | 133/233 (57.1) | NS |
| LDA + LMWH therapeutic dosage (n = 50) | 10/50 (20) | 40/233 (17.2) | NS |
| LDA + LMWH, start at positive pregnancy test (n = 143) | 28/50 (56) | 115/233 (49.3) | NS |
| LDA + LMWH, start between 6 and 8 weeks of gestation (n = 16) | 0/50 (0) | 16/233 (6.8) | NS |
| LDA + LMWH, Start between 9 and 12 weeks of gestation (n = 22) | 6/50 (12) | 16/233 (6.8) | NS |
| LDA + LMWH, start after 12 weeks of gestation (n = 30) | 4/50 (8) | 26/233 (11.1) | NS |
| Hydroxychloroquine (n = 32) | 6/50 (12) | 26/233 (11.2) | NS |
| Steroids (n = 16) | 4/50 (8) | 12/233 (5.1) | NS |
LDA, low-dose aspirin; LMWH, low-molecular-weight heparin.
*OR 7.37; CI 95% 0.96–65.